FIELD GUIDE AND DRUG LIST

Size: px
Start display at page:

Download "FIELD GUIDE AND DRUG LIST"

Transcription

1 FIELD GUIDE AND DRUG LIST CONTINENTAL CARE INSURANCE Continental Life Insurance Company of Brentwood, Tennessee (CLI) An Aetna Company CLICC

2 FIELD GUIDE Always take enough time with every applicant to assure that they fully understand all application questions and terminology. Applications for coverage will be rejected for the following: Anyone other than the applicant supplies the answers to the questions and signs the application. The applicant did not know they applied for insurance. The applicant is unwilling to complete a telephone interview. (Telephone interviews will be completed with all applicants.) Please advise the applicant to expect a call. If the application was submitted with a check from a third-party payor that has no family (spouse/partner, child, etc.) or business relationship (business owner, employee or retiree of the business). No premium or electronic funds transfer information is submitted with the application. CHOOSING AN EFFECTIVE DATE The effective date must be on or after the date of the application and, normally, will be the date the policy is issued.

3 UNDERWRITING Applications are underwritten up until the time the policy is issued. If a declinable health condition emerges between the time the application was taken and the time of policy issuance, the application will be declined. A yes answer to any part of Question 3 will automatically disqualify the applicant and the application should not be submitted. Questions on the telephone interview are identical to the application questions; however, questions concerning current medications and physicians being seen are also included in the interview. While the application form does not include a medications question, it is always advisable on any application to ask the applicant for medications currently being taken. Listing the medications may prompt the applicant to remember a condition, included in the application, which he/she may have overlooked. Certain medications may indicate a condition that is included in the application. The following Drug Information List contains commonly prescribed medications that are prescribed for conditions listed on the application; however, new drugs are regularly introduced and may not be included but may be unacceptable. Any questions concerning questionable medications should be directed to the Underwriting Department. A discussion of physicians being seen is helpful in determining eligibility. An applicant who is seeing certain specialists may suggest a condition included in the application; for example, an Oncologist may indicate treatment for cancer or a Nephrologist may indicate treatment for an unacceptable kidney problem. Other specialties that may suggest an unacceptable condition are Cardiologist, Hepatologist, and Psychiatrist. For questions, the Underwriting Department can be reached at , option 3.

4 DRUG LIST Abilify Actigall Actimmune Adriamycin Adrucil *Akineton for: alemtuzumab Alferon Alkeran *amantadine for: ambenonium Anandron anastrazole Aredia Aricept Arimidex aripiprazole *Artane for: Avonex AZT (azidothymidine) Azilect *baclofen for: multiple sclerosis benztropine Betaseron Bexxar bicalutamide *biperiden Blenoxane bleomycin bromocriptine bumetanide Bumex busulfan Busulfex calcium acetate Campath capectabine *carbidopa for: Casodex CeeNu Cerubidine chlorambucil chlorpromazine cisplatin clozapine Clozaril Cogentin Cognex Comtan Cosmegen cyclophosphamide cytarabine Cytosar Cytoxan dactinomycin Dantrium dantrolene daunorubicin *Demadex didanosine dideoxyinosine Disipal

5 docetaxel donepezil *Dopar for: doxorubicin Droxia edrophonium Eldepryl Eligard Eloxatin Emcyt Enlon entacapone epoetin alfa Epogen ergoloid mesylates Eskalith estramustine etoposide Eulexin Exelon Faslodex Femara floxuridine fluorouracil fluphenazine flutamide foscarnet sodium Foscavir FUDR fulvestrant galantamine gamma interferon gefitinib gemtuzumab Geodon Gleevex goserelin Haldol haloperidol Hydergine Hydrea hydroxyurea imatinib interferon alpha 2a interferon alpha 2b interferon beta Intron A Invega Iressa Kemadrin *Laradopa for: lenalidomide letrozole Leukeran leuprolide *levodopa for: *Lioresal for: multiple sclerosis Lithane lithium Lithobid *Lodosyn for: lomustine loxapine Loxitane Lupron Lysodren Matulane mechlorethamine Megace megestrol

6 Mellaril melphalan memantine mercaptopurine (6MP) mesoridazine methotrexate Mestinon Mexate *Mirapex for: Mithracin mitomycin mitotane Moban molindone Mustargen Mutamycin Myleran Mylotarg Mytelase Namenda Nardil Navane Nebupent neostigmine Nilandron nilutamide olanzapine Oncovin orphenadrine oxaliplatin paclitaxel paliperidone pamidronate Parlodel Pentam pentamidine perphenazine phenelzine Phoslo Platinol plicamycin *pramipexole for: procarbazine Procrit procyclidine Prolixin Prostigmin Purinethol (6MP) pyridostigmine quetiapine rasagiline Razadyne Rebif Reminyl *Requip for: Retrovir Revlimid Rilutek riluzole Risperdal risperidone Rituxan rivastigmine Roferon-A *ropinirole for: Parkinsons Disease selegiline Serentil Seroquel

7 *Sinemet for: Stelazine *Symmetrel for: Tabloid tacrine Taxol Taxotere Tensilon Teslac testolactone tetrabenazine thioguanine Thioplex thioridazine thiotepa thiothixene Thorazine torsemide tositumomab Trelstar LA trifluoperazine trihexyphenidyl Trilafon triptorelin pamoate Urso ursodiol Velban VePesid Viadur Videx vinblastine vincristine Wellferon Xeloda Xenazine Zelapar zidovudine, AZT ziprasidone Zoladex zoledronic acid Zometa Zyprexa lower case: generic name Upper Case: brand name

8 Continental Life Insurance Company of Brentwood, Tennessee An Aetna Company aetnaseniorproducts.com 2012 Aetna Inc.

DECLINABLE DRUG LIST

DECLINABLE DRUG LIST DECLINABLE DRUG LIST Individual Whole Life Insurance indicates that the drug will result in a decline. Make sure to list ALL medications on the application. Prescription medications may be used for multiple

More information

The long-term care underwriting process

The long-term care underwriting process Long-term Care (LTC) Rider This information does not apply to the Nationwide YourLife CareMatters product. Underwriting long-term care coverage differs greatly from general life insurance underwriting

More information

Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC

Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC Medication Review Cancer Chemotherapy Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Cancer Chemotherapy Drugs PassAssured's Pharmacy Technician Training Program Medication

More information

supplemental Benefits DECLINABLE DRUG LIST

supplemental Benefits DECLINABLE DRUG LIST supplemental Benefits DECLINABLE DRUG LIST This Declinable Drug List applies to Medicare Supplement Insurance insured by American Retirement Life Insurance Company. Always determine how the medication

More information

Acute Lymphocytic Leukemia

Acute Lymphocytic Leukemia Acute Lymphocytic Leukemia Splenectomy (Removal of Spleen) 6-Mercaptopurine (Purinethol, 6-MP) Alemtuzumab (Campath ) Arsenic Trioxide (Trisenox ) Bendamustine (Treanda ) Bexarotene (Targretin ) Bleomycin

More information

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1 drug and administration compendia Current Price () J7506 Prednisone, oral, per 5 mg 12/1/07 $0.07 $0.19 N/A prednisone 2 J8520 capecitabine (Xeloda) 1 Capecitabine, oral, 150 mg 8/1/07 $5.79 $4.59 N/A

More information

Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class

Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Cancer LAST REVIEW 9/11/18 THERAPEUTIC CLASS Oncology REVIEW HISTORY 5/17, 5/16 LOB AFFECTED Medi-Cal (MONTH/YEAR) This policy

More information

Field Prescription Drug Guide

Field Prescription Drug Guide Field Prescription Drug Guide The following Guide is designed to assist you when writing a Preferred, Standard or Modified Whole Life application. It discloses the most widely used prescriptions and usage.

More information

UNDERWRITING GUIDE. Secure Advantage HOSPITAL COVERAGE. The Insurance Policy That Pays You Cash In The Event Of A Covered Hospitalization

UNDERWRITING GUIDE. Secure Advantage HOSPITAL COVERAGE. The Insurance Policy That Pays You Cash In The Event Of A Covered Hospitalization UNDERWRITING GUIDE Secure Advantage HOSPITAL COVERAGE The Insurance Policy That Pays You Cash In The Event Of A Covered Hospitalization TABLE OF CONTENTS Contents Page Secure Advantage Underwriting Guide...2

More information

Exhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A

More information

Fundamentals of Pharmacology for Veterinary Technicians Chapter 20

Fundamentals of Pharmacology for Veterinary Technicians Chapter 20 Figure 20-1 Figure 20-2 Figure 20-3A Figure 20-3B Figure 20-4 Table 20-1 Antineoplastic Agents Used for Chemotherapy in Animals Drug Type Drug Category Examples Cell-Cycle Effect CCNS Alkylating agents:

More information

Pre-qualification impairment guide

Pre-qualification impairment guide SecureCare Universal Life Individual Life and Long-Term Care Insurance Insurance products issued by: MINNESOTA LIFE INSURANCE COMPANY Pre-qualification impairment guide Complete the following steps to

More information

EquiCash UNDERWRITING GUIDE. Equitable &You. The Policy That Pays You Cash In The Event You Have To Be Hospitalized HOSPITAL PLAN

EquiCash UNDERWRITING GUIDE. Equitable &You. The Policy That Pays You Cash In The Event You Have To Be Hospitalized HOSPITAL PLAN UNDERWRITING GUIDE EquiCash HOSPITAL PLAN The Policy That Pays You Cash In The Event You Have To Be Hospitalized Rev. 10/13 Equitable &You... Committed To Caring TABLE OF CONTENTS Contents Page EquiCash

More information

Antipsychotic Medication

Antipsychotic Medication Antipsychotic Medication Mary Knutson, RN 3-7-12 Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Clinical Uses of Antipsychotics Short-term: in severe depression and

More information

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS

More information

Introduction to Antineoplastic Prescribing

Introduction to Antineoplastic Prescribing Introduction to Antineoplastic Prescribing Robert Bradbury, R.Ph., BCPS Clinical Coordinator H. Lee Moffitt Cancer Center Objectives Meet the following goals concerning antineoplastic prescribing: Understand

More information

Step Two Phone Verification Call (PVC) and Pharmacy Screen: Applicant s Age Phone Verification Call (PVC) Details Pharmacy Screen

Step Two Phone Verification Call (PVC) and Pharmacy Screen: Applicant s Age Phone Verification Call (PVC) Details Pharmacy Screen TM Underwriting Process Issue ages 18-85 Step One 10 Yes/No Application Questions: Applicant must answer all 10 questions. If the client answers any of these questions yes, DO NOT SUBMIT. Not insurable.

More information

Chemotherapy and biotherapy: guidelines and recommendations for practice.

Chemotherapy and biotherapy: guidelines and recommendations for practice. Complete Summary GUIDELINE TITLE Chemotherapy and biotherapy: guidelines and recommendations for practice. BIBLIOGRAPHIC SOURCE(S) Oncology Nursing Society (ONS). Chemotherapy and biotherapy: guidelines

More information

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black

More information

Chemotherapy 101 for Radiation Oncology Workers

Chemotherapy 101 for Radiation Oncology Workers Chemotherapy 101 for Radiation Oncology Workers James Sinclair, M.D. CCARE/Medical Director Scripps Cancer Center March 9, 2013 Category 1) Alkylating agents Alkylating agents directly damage DNA to prevent

More information

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08.

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08. Clinical Policy: (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy for important

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management

More information

Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you.

Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you. Thank you for choosing Pine Rest Christian Mental Health Services. We look forward to providing services to you. In order to make the most of your first appointment, please come at least 30 minutes prior

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Abilify Maintena, Aristada, Aristada Initio) Reference Number: CP.PHAR.290 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid Coding Implications Revision Log

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

Who is Bearing the Cost?

Who is Bearing the Cost? THE COS ST T OF CANCE R DRUGS IN CANADA PA R T 2 Who is Bearing the Cost? KONG KHOO, ROSEMARY COLUCCI, WILLIAM HRYNIUK, ROBERT KAMINO, TANIA REDINA AND COLLEEN SAVAGE Introduction Last year we reported

More information

Ovarian Cancer. compendia TREATMENT OF

Ovarian Cancer. compendia TREATMENT OF drug & compendia TREATMENT OF Ovarian Cancer With each publication, ManagedCare Oncology s drug & Compendia highlights a single medication or a group of medications that could be utilized in the management

More information

ANTIPSYCHOTICS/ NEUROLEPTICS

ANTIPSYCHOTICS/ NEUROLEPTICS Pharmacological Interventions Tutorial Antipsychotic medications First Generation (Typicals) Includes phenothiazines, thioxanthenes, butyrophenones ANTIPSYCHOTICS/ NEUROLEPTICS Second Generation (Atypicals)

More information

May 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator:

May 22, DAL: DAL SUBJECT: Hot Weather Advisory. Dear Administrator/Operator: May 22, 2013 DAL: DAL 13-11 SUBJECT: Hot Weather Advisory Dear Administrator/Operator: The New York State Department of Health would like to remind you of our expectations regarding the protection of Adult

More information

New Patient Information - Adolescent

New Patient Information - Adolescent Scanned Ages 12-17 Dear Parent: To help your clinician understand and help your child, please answer the questions on this form and bring it with you to your child s first appointment. Please print using

More information

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies: VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Incidence: The incidence of acute and delayed N&V was investigated in highly and moderately emetogenic

More information

To help doctors give their patients the best possible care, the American

To help doctors give their patients the best possible care, the American Patient Information Resources from ASCO What to Know ASCO s Guideline on Preventing Vomiting Caused by Cancer Treatment SEPTEMBER 2011 KEY MESSAGES The risk of nausea and vomiting depends on the specific

More information

What Team Members Other Than Prescribers Need To Know About Antipsychotics

What Team Members Other Than Prescribers Need To Know About Antipsychotics What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State

More information

Michael J. Bailey, M.D. OptumHealth Public Sector

Michael J. Bailey, M.D. OptumHealth Public Sector Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)

More information

Drug List Aetna Senior Supplemental Insurance

Drug List Aetna Senior Supplemental Insurance Drug List Aetna Senior Supplemental Insurance Effective date: 05/04/2018 For agent use only. Not for public use or distribution. CGFLP04363 2018 Aetna Inc. 050418 Drug list information We provide this

More information

Hospice Skills Checklist

Hospice Skills Checklist _ XXX-XX- Print Name Last 4 of SS # Date Completed Directions Please circle a value for each question to provide us and the interested facilities with an assessment of your clinical experience. These values

More information

New Patient Questionnaire

New Patient Questionnaire 813-981-4403 Fax 813-852-6830 3903 Northdale Blvd Suite 100E Tampa, FL 33624 New Patient Questionnaire Date / / Name First Last DOB Age Sex: Male Female Ethnicity: White African-American American Indian

More information

Oncology Skills Checklist

Oncology Skills Checklist _ XXX-XX- Print Name Last 4 of SS # Date Completed Directions Please circle a value for each question to provide us and the interested facilities with an assessment of your clinical experience. These values

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA

More information

Underwriting Guidelines. for Total Living Coverage

Underwriting Guidelines. for Total Living Coverage Underwriting Guidelines for Total Living Coverage Underwriting Guidelines Pre-Qualifying Questions Underwriting Conditions Underwriting Classes Underwriting Life Rates Preferred Life Criteria Preferred

More information

Antipsychotics and stroke risk

Antipsychotics and stroke risk Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year Antipsychotics and stroke risk Lockwood G. Taylor, PhD, MPH Division of Epidemiology II Office of Pharmacovigilance

More information

Leukemia. Treatment of. compendia. Associated ICD-9-CM Codes: Drug & Administration. managedcareoncology.com

Leukemia. Treatment of. compendia. Associated ICD-9-CM Codes: Drug & Administration. managedcareoncology.com Drug & compendia Treatment of Leukemia With each publication, Managed Care Oncology s Drug & Compendia highlights a single medication or a group of medications that could be utilized in the management

More information

Disclosures. Objectives. What s Shaking? Tremors and Movement Disorders

Disclosures. Objectives. What s Shaking? Tremors and Movement Disorders Disclosures What s Shaking? Tremors and Movement Disorders Jill L. Ostrem, MD Associate Professor of Neurology Surgical Movement Disorders Center Consultant and speaker: Allergan Inc., Medtronic Inc.,

More information

Antipsychotic Medications Age and Step Therapy

Antipsychotic Medications Age and Step Therapy Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana

More information

Psychotropic Medications Affect Body Heat 3/4. Heat Exhaustion A U G U S T Y E A R 28, I S S UE 8. Inside this issue Page

Psychotropic Medications Affect Body Heat 3/4. Heat Exhaustion A U G U S T Y E A R 28, I S S UE 8. Inside this issue Page A U G U S T 20 17 Y E A R 28, I S S UE 8 The Club Gazette Blue Earth County - Second Step Clubhouse Our Mission: Second Step believes that persons with mental illness have the right to reach their full

More information

Overview of Cancer. Laura Bingell RN Transition Center Nurse for MFP (607)

Overview of Cancer. Laura Bingell RN Transition Center Nurse for MFP (607) Overview of Cancer Laura Bingell RN Transition Center Nurse for MFP (607)962-8225 lbingell@ilny.org What is Cancer? A collection of related diseases in which some of the body s cells begin to divide abnormally

More information

Field Prescription Drug Guide

Field Prescription Drug Guide Field Prescription Drug Guide The following Guide is designed to assist you when writing a Preferred, Standard or Modified Whole Life application. It discloses the most widely used prescriptions and usage.

More information

HCA BHS Prescribing Guidelines Committee - Approved Medications 2012

HCA BHS Prescribing Guidelines Committee - Approved Medications 2012 Amitriptyline/Perphenazine Triavil MAJOR TRANQUILIZERS Beneficiaries 10/2, 10/4, 25/2, 25/4, 50/4 Aripiprazole Abilify 2mg, 5mg, 10mg, 15mg, 20mg, 30mg Quantity Limit 31 / mo for Asenapine Saphris 5mg,

More information

30. Beta Adrenergic Receptor Blocking Agents Acebutolol Carteolol (Cartrol) February 12, 2003 Penbutolol (Levatol) Propranolol (Inderal LA)

30. Beta Adrenergic Receptor Blocking Agents Acebutolol Carteolol (Cartrol) February 12, 2003 Penbutolol (Levatol) Propranolol (Inderal LA) #03-01 Prior Authorization PDL Implementation Schedule UPDATES Drugs on PDL Drugs which Require PA Implementation Date 26. Bone Resorption Suppression Agents Alendronate (Fosamax) Etidronate (Didronel)

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

3/11/2014. Welcome. Disclosure. Diagnosing, Interventions and End-of-Life Planning

3/11/2014. Welcome. Disclosure. Diagnosing, Interventions and End-of-Life Planning Diagnosing, Interventions and End-of-Life Planning Welcome We are informing you: The planning committee and faculty have a conflict of interest as they are employees of Great Lakes Caring. They have agreed

More information

475 GERIATRIC PSYCHOPHARMACOLOGY (p.1)

475 GERIATRIC PSYCHOPHARMACOLOGY (p.1) 475 GERIATRIC PSYCHOPHARMACOLOGY (p.1) I. General Information? Use lower doses? Start low and go slow? Expect prolonged elimination ½ lives? Expect sedative-hypnotics to be dementing, to impair cognitive

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

Bladder Cancer Pathways (Urothelial)

Bladder Cancer Pathways (Urothelial) Bladder Cancer Pathways (Urothelial) Patient Name: Date of Birth: Member Number: Treatment Start Date: ICD-10 Code: Pathology: Stage: 0a 0is I II III IV Recurrent Line of Treatment: Neoadjuvant/Pre-Op

More information

#55 PRESCRIBING AND MONITORING PSYCHI RIC MEDICATIONS

#55 PRESCRIBING AND MONITORING PSYCHI RIC MEDICATIONS - '_ ADMINISTRA TIVE/FISCAUCLINICAL/PHF POLICY AND PROCEDURES COUNTY OF SANTA BARBARA ALCOHOL, DRUG AND MENTAL HEAL TH SERVICES Section - QUALITY ASSURANCE Effective: 12/1/09 Policy- Director's Approval

More information

Within Best Plan Medication Prescribed For Time Frame Available

Within Best Plan Medication Prescribed For Time Frame Available This list is provided as a courtesy to assist Settlers Life s appointed representatives with field underwriting. We will work with our Medical Director to keep this list as current as possible, but it

More information

The Ins and Outs of PD Meds. Johanna Hartlein, APRN, MSN Family Nurse Practitoner and Great Hugger Washington University School of Medicine

The Ins and Outs of PD Meds. Johanna Hartlein, APRN, MSN Family Nurse Practitoner and Great Hugger Washington University School of Medicine The Ins and Outs of PD Meds Johanna Hartlein, APRN, MSN Family Nurse Practitoner and Great Hugger Washington University School of Medicine Words of Caution Just because I list a possible side effect, it

More information

Form 2023 R2.0: Ovarian Cancer Pre-HSCT Data

Form 2023 R2.0: Ovarian Cancer Pre-HSCT Data Key Fields Sequence Number Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Today's Date: - - Date of HSCT for which this form is being completed: - - HSCT type: (check all that apply) Autologous

More information

DRUG PROPERTIES YOU NEED TO KNOW

DRUG PROPERTIES YOU NEED TO KNOW jfitzake@d.umn.edu www.d.umn.edu/~jfitzake Page 1 of 8 DRUG PROPERTIES YOU NEED TO KNOW 1. Mechanism of action a. chemical class b. resistance 2. Pharmacokinetics 3. Therapeutic uses 4. Major side effects/toxicities

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

AAA. add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders AAA Adolescents & Adults with Autism A Study of Family Caregiving add dan campbell artwork cats? Report #12 Changes in Medication Use over Time in Adolescents and Adults with Autism Spectrum Disorders

More information

Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006

Access To Cancer Drugs In Medicare Part D: Formulary Placement And Beneficiary Cost Sharing In 2006 Access To Cancer Drugs In Medicare Part D: Formulary Placement And eneficiary Cost Sharing In 2006 Medicare Part D beneficiaries have access to many more cancer drugs than ever before, with low cost sharing.

More information

APPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC)

APPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC) APPENDIX E COMMONLY PRESCRIBED MEDICATIONS BY CATEGORY BY BRAND (GENERIC) Revised June 2005 Page E-1 Prescribed Medications by Category by Brand This is not an all-inclusive list ANTIPSYCHOTICS ANTIDEPRESSANTS

More information

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine

More information

MEDICATION INFORMATION MANUAL

MEDICATION INFORMATION MANUAL STATE OF NEW JERSEY DEPARTMENT OF HUMAN SERVICES DIVISION OF MENTAL HEALTH SERVICES MEDICATION INFORMATION MANUAL Kevin Martone Assistant Commissioner State of New Jersey Division of Mental Health Services

More information

Allergy: Levocetirizine (Xyzal) (F) Desloratadine (Clarinex) (NF) OTC Cetirizine (Zyrtec) (NF) OTC Loratadine (Claritin) (NF) Dexchlorpheniramine

Allergy: Levocetirizine (Xyzal) (F) Desloratadine (Clarinex) (NF) OTC Cetirizine (Zyrtec) (NF) OTC Loratadine (Claritin) (NF) Dexchlorpheniramine Anticholinergics Brompheniramine Carbinoxamine Chlorpheniramine Clemastine Cyproheptadine Highly anticholinergic, clearance reduced with advanced age, and tolerance develops when used as hypnotic; greater

More information

Cancer, Heart Attack and Stroke Insurance

Cancer, Heart Attack and Stroke Insurance Cancer, Heart Attack and Stroke Insurance AGENT RATE AND UNDERWRITING GUIDE CONNECTICUT - MONTHLY FOR AGENT USE ONLY UNDERWRITTEN BY: Guarantee Trust Life Insurance Company GUARANTEE TRUST LIFE INSURANCE

More information

Psychosis, Delirium, Dementia

Psychosis, Delirium, Dementia Psychosis, Delirium, Dementia Melinda M. Spencer Smith, DNP, ACNS-BC, APRN Bertia A. Spencer Jennings, DNP, PPCNP, PMHS, BC Intentions and Limitations of Training Introduction Psychosis, Delirium, Dementia

More information

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS

MABCAMPATH mg 3 INJ GENZYME BIOPHARMACEUTICALS. MABCAMPBATH mg 3 INJ GENZYME BIOPHARMACEUTICALS ICON Formulary - November 2016 Class Medicine Name Nappi Strength Form Size Route Manufacturer Abiraterone Acetate ZYTIGA 250 720690001 250 mg 120 ORAL JANSSEN PHARMACEUTICALS Aldesleukin CHIRON IL-2 18

More information

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Slide 1 Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Flavio Guzmán, MD Slide 2 About this module 13 antipsychotics will be studied 3 first generation antipsychotics 10 second

More information

Dealing with a Mental Health Crisis

Dealing with a Mental Health Crisis Dealing with a Mental Health Crisis Information and Resources for First Responders P... PROFESSIONAL WHAT NAMI DOES NAMI Minnesota is a statewide 501(c)(3) grassroots nonprofit organization dedicated to

More information

Cancer, Heart Attack and Stroke Insurance

Cancer, Heart Attack and Stroke Insurance Cancer, Heart Attack and Stroke Insurance AGENT RATE AND UNDERWRITING GUIDE Basic - Monthly AL, DC, ID, IL, IA, KS, KY, LA, ME, MI, MS, NE, NM, NC, ND, OH, OK, PA, SC, TX, WV, WI FOR AGENT USE ONLY UNDERWRITTEN

More information

IR PROCEDURE REFERENCE GUIDE

IR PROCEDURE REFERENCE GUIDE IR PROCEDURE REFERENCE GUIDE Procedure Scan Involvement Preparation Length For Procedure CT CT BIOPSIES/ DRAINS Done per Radiologist in CT (Must be pre-approved by Radiologist) NPO after midnight or 6

More information

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Drug/Drug Class Antipsychotics Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria Prior

More information

MEDICAL NECESSITY GUIDELINE

MEDICAL NECESSITY GUIDELINE PAGE: 1 of 10 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted

More information

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial

More information

U T I L I Z A T I O N E D I T S

U T I L I Z A T I O N E D I T S I N D I A N A H E A L T H C O V E R A G E P R O G R A M S U T I L I Z A T I O N E D I T S A P R I L 1 9, 2 0 1 2 s for s Refer to Provider Bulletin BT200709 for additional information regarding the Mental

More information

Bladder Cancer (Urothelial) Pathways

Bladder Cancer (Urothelial) Pathways Bladder Cancer (Urothelial) Pathways Patient Name: Date of Birth: Member Number: Treatment Start Date: ICD-10 Code: Pathology: Stage: 0a 0is I II III IV Recurrent Line of Treatment: Neoadjuvant/Pre-Op

More information

DRUGS YOU NEED TO KNOW

DRUGS YOU NEED TO KNOW jfitzake@d.umn.edu Page 1 of 7 DRUGS YOU NEED TO KNOW ALKYLATING AGENTS (blue cards) BUSULFAN CARMUSTINE (BCNU) CYCLOPHOSPHAMIDE DACARBAZINE LOMUSTINE (CCNU) MECHLORETHAMINE MELPHALAN THIOTEPA NATURAL

More information

How did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh

How did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh Polypharmacy, Adverse Effects, and the Importance of Tapering Medications for People with Intellectual and Developmental Disabilities Garrett McCann, RPh How did we get here? 1876 Methylene Blue Insecticide

More information

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For

More information

Objectives. Principles of Cancer Treatment. Cancer Treatment Modalities. Cancer Treatment Modalities

Objectives. Principles of Cancer Treatment. Cancer Treatment Modalities. Cancer Treatment Modalities Objectives Principles of Cancer Treatment Juanita Madison, RN, MN, AOCN Oncology Clinical Nurse Specialist Seattle Cancer Care Alliance Describe the principles of cancer treatment Surgery Chemotherapy

More information

ALKYLATING AGENTS (22)

ALKYLATING AGENTS (22) Serving the United States, Canada and North Central America MEMBER OF TEXAS HEALTH CARE ENTITIES A PRIVATE MEMBERSHIP MEDICAL ASSOCIATION 3105 MAIN STREET, ROWLETT, TX 75088 TEL: 214-299-9449 office@rgccusa.com

More information

Medications and Falls Part 2

Medications and Falls Part 2 Medications and Falls Part 2 Risk Evaluation of Non Cardiovascular Medications, Polypharmacy, and Abnormal Serum Chemistries Dennis J Chapron reports no real or potential conflicts of interest relevant

More information

Medications and Falls Part 2

Medications and Falls Part 2 Medications and Falls Part 2 Risk Evaluation of Non Cardiovascular Medications, Polypharmacy, and Abnormal Serum Chemistries Dennis J Chapron Medication Safety Pharmacist Saint Francis Hospital and Medical

More information

UP Health System Marquette Medication Guideline High Alert Drugs

UP Health System Marquette Medication Guideline High Alert Drugs 1 ALTEPLASE SOLR 100 MG ACTIVASE 305010 50242008527 TRUE ALTEPLASE SOLR 50 MG ACTIVASE 305008 50242004413 TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV 305035 63323061609 TRUE AMIODARONE INJ 50 MG/ML CORDARONE

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

Disclosures. Objectives. What s Shaking? Tremors and Movement Disorders

Disclosures. Objectives. What s Shaking? Tremors and Movement Disorders Disclosures What s Shaking? Tremors and Movement Disorders Jill L. Ostrem, MD Associate Professor of Neurology Surgical Movement Disorders Center Consultant and speaker: Allergan Inc., Medtronic Inc.,

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Coverage Guidelines are subject to change as new information becomes available. ZELAPAR (selegiline hydrochloride) orally disintegrating tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Supportive Care in Cancer Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database Romina Sosa, Shuling Li, Julia T. Molony, Jiannong

More information

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric

More information

Appendix 2: Admissions checklists for people with Parkinson s

Appendix 2: Admissions checklists for people with Parkinson s Appendix 2: Admissions checklists for people with Parkinson s This document is intended to form the basis of a locally developed tool and so it has been built to be amended with relevant local information,

More information

2. Date of most recent breast cancer diagnosis / / 3. Pathlogy: Padget s Phyllodes Tubular Medullary Mucinous

2. Date of most recent breast cancer diagnosis / / 3. Pathlogy: Padget s Phyllodes Tubular Medullary Mucinous Breast Cancer Patients: Begin on page 1, then skip to page 3 Lymphoma Patients: Begin on page 2 1. Newly diagnosed with Breast carcinoma Stage: (includes inflammatory breast and newly diagnosed recurrent

More information

Psychiatric Intake Form (Please note: if you are not comfortable answering any of the following questions, feel free to leave the space blank)

Psychiatric Intake Form (Please note: if you are not comfortable answering any of the following questions, feel free to leave the space blank) Past Psychiatric History: What issues or symptoms bring you to this practice? When did these symptoms start? Are the symptoms constant or intermittent? List any previous psychiatric conditions you have

More information